Previous studies have shown that CPT1A expression is reduced in AKI and CKD models [22,23], while its overexpression protects against CKD-associated fibrosis, improving the mitochondrial membrane potential and preventing mitochondrial dysfunction [24]. The gene discussed is CPT1A; the disease is chronic kidney disease.